Adam J. Litterman

1.1k total citations
20 papers, 571 citations indexed

About

Adam J. Litterman is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Adam J. Litterman has authored 20 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in Adam J. Litterman's work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers) and RNA Research and Splicing (4 papers). Adam J. Litterman is often cited by papers focused on CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers) and RNA Research and Splicing (4 papers). Adam J. Litterman collaborates with scholars based in United States, China and Japan. Adam J. Litterman's co-authors include John R. Ohlfest, Richard L. Shapiro, David Polsky, Elise Ng, Paul J. Christos, Russell S. Berman, Farbod Darvishian, Anna C. Pavlick, Iman Osman and Andres Μ. Salazar and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Adam J. Litterman

19 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam J. Litterman United States	11	349	272	172	125	46	20	571
Oriana E. Hawkins United States	16	277 0.8×	290 1.1×	326 1.9×	62 0.5×	36 0.8×	19	687
Akira Yuno United States	16	459 1.3×	411 1.5×	383 2.2×	66 0.5×	22 0.5×	29	844
Alice Melotti Italy	6	242 0.7×	267 1.0×	229 1.3×	93 0.7×	103 2.2×	7	609
Lesley A. Mathews Griner United States	11	273 0.8×	158 0.6×	148 0.9×	39 0.3×	43 0.9×	18	514
Chi-Ping Day United States	6	243 0.7×	253 0.9×	88 0.5×	110 0.9×	27 0.6×	6	582
Henrik Jespersen Sweden	15	349 1.0×	425 1.6×	310 1.8×	89 0.7×	18 0.4×	25	787
Boris Brill Germany	15	266 0.8×	183 0.7×	177 1.0×	61 0.5×	62 1.3×	33	578
Silke Raffegerst Germany	11	183 0.5×	240 0.9×	309 1.8×	98 0.8×	32 0.7×	19	541
Gangjun Lei United States	14	288 0.8×	317 1.2×	273 1.6×	131 1.0×	16 0.3×	23	653
Qian Zhu China	15	403 1.2×	303 1.1×	116 0.7×	126 1.0×	16 0.3×	36	658

Countries citing papers authored by Adam J. Litterman

Since Specialization

Citations

This map shows the geographic impact of Adam J. Litterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Litterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Litterman more than expected).

Fields of papers citing papers by Adam J. Litterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Litterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Litterman. The network helps show where Adam J. Litterman may publish in the future.

Co-authorship network of co-authors of Adam J. Litterman

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Litterman. A scholar is included among the top collaborators of Adam J. Litterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Litterman. Adam J. Litterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heo, Seok‐Jin, Scot Federman, Phuong T. Nguyen, et al.. (2024). Compact CRISPR genetic screens enabled by improved guide RNA library cloning. Genome biology. 25(1). 25–25. 6 indexed citations

Zhu, Wandi S., Adam J. Litterman, Robin Kageyama, et al.. (2023). GCLiPP: global crosslinking and protein purification method for constructing high-resolution occupancy maps for RNA binding proteins. Genome biology. 24(1). 281–281. 2 indexed citations

Gagnon, John D, Adam J. Litterman, Dina Polyak, et al.. (2022). Abstract 2830: Multiplexed shRNAs targeting FAS and PTPN2 enhance CAR T persistence and anti-tumor efficacy. Cancer Research. 82(12_Supplement). 2830–2830.

Wigton, Eric J., Yohei Mikami, Carlos A. Castellanos, et al.. (2021). MicroRNA-directed pathway discovery elucidates an miR-221/222–mediated regulatory circuit in class switch recombination. The Journal of Experimental Medicine. 218(11). 11 indexed citations

Gagnon, John D, Robin Kageyama, Hesham M. Shehata, et al.. (2019). miR-15/16 Restrain Memory T Cell Differentiation, Cell Cycle, and Survival. Cell Reports. 28(8). 2169–2181.e4. 63 indexed citations

Litterman, Adam J., Robin Kageyama, Olivier Le Tonquèze, et al.. (2019). A massively parallel 3′ UTR reporter assay reveals relationships between nucleotide content, sequence conservation, and mRNA destabilization. Genome Research. 29(6). 896–906. 33 indexed citations

Chatrikhi, Rakesh, Michael J. Mallory, Matthew R. Gazzara, et al.. (2019). RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery. Cell Reports. 28(11). 2795–2806.e3. 31 indexed citations

Sennino, Barbara, Andrew Conroy, Bhamini Purandare, et al.. (2019). Abstract 1433: NeoTCR-P1, a novel neoepitope-specific adoptive cell therapy, consists of T cells with ‘younger’ phenotypes that rapidly proliferate and kill target cells upon recognition of cognate antigen. Cancer Research. 79(13_Supplement). 1433–1433. 2 indexed citations

Jacoby, Kyle, Robert Moot, William Lu, et al.. (2019). Abstract 4783: Highly efficient, non-viral precision genome engineering for the generation of personalized neoepitope-specific adoptive T cell therapies. Cancer Research. 79(13_Supplement). 4783–4783. 1 indexed citations

10.

Gagnon, John D, Robin Kageyama, Hesham M. Shehata, et al.. (2018). miR-15/16 Restrain Memory T Cell Differentiation, Cell Cycle, and Survival. SSRN Electronic Journal. 1 indexed citations

11.

Jin, Fang, Adam J. Litterman, Alexis J. Balgeman, et al.. (2015). Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses. PLoS ONE. 10(5). e0125565–e0125565. 19 indexed citations

12.

Litterman, Adam J., et al.. (2014). Antigen-Specific Culture of Memory-like CD8 T Cells for Adoptive Immunotherapy. Cancer Immunology Research. 2(9). 839–845. 5 indexed citations

13.

Litterman, Adam J., Arkadiusz Z. Dudek, & David A. Largaespada. (2013). Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination. OncoImmunology. 2(10). e26294–e26294. 16 indexed citations

14.

Skinner, Nicole, Sara E. Hamilton, Adam J. Litterman, et al.. (2013). Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses. Molecular Therapy. 21(8). 1526–1535. 46 indexed citations

15.

Litterman, Adam J., et al.. (2013). Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy. The Journal of Immunology. 190(12). 6259–6268. 54 indexed citations

16.

Yancovitz, Molly, Adam J. Litterman, Elise Ng, et al.. (2012). Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma. PLoS ONE. 7(1). e29336–e29336. 212 indexed citations

17.

Ohlfest, John R., Brian M. Andersen, Adam J. Litterman, et al.. (2012). Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model. The Journal of Immunology. 190(2). 613–620. 50 indexed citations

18.

Olin, Michael R., Brian M. Andersen, Adam J. Litterman, et al.. (2011). Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells. Cancer Research. 71(21). 6583–6589. 17 indexed citations

19.

Litterman, Adam J., Molly Yancovitz, Richard L. Shapiro, et al.. (2009). Detection of BRAF kinase mutations in melanoma, ovarian, and prostate carcinomas: Evidence for tumor heterogeneity in clinical samples. Journal of Clinical Oncology. 27(15_suppl). 11031–11031. 1 indexed citations

20.

Litterman, Adam J., Melanie Warycha, Richard L. Shapiro, et al.. (2008). Tumor heterogeneity: Evidence from BRAF V600E mutation detection. Journal of Clinical Oncology. 26(15_suppl). 20022–20022. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact